This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignees: Intervet International B.v., Universitât Bern. Active years: 2014.
Company Filing History:
1 out of 107 
1 out of 67 
Years Active: 2014
Title: The Innovations of Keith Redhead
Introduction
Keith Redhead is a notable inventor based in Milton Keynes, GB. He has made significant contributions to the field of biotechnology, particularly through his research on toxins. His work has implications for understanding cytotoxic activities and their effects on various species.
Latest Patents
Keith Redhead holds 1 patent. His patent pertains to the identification and initial characterization of CctA, a novel secreted toxin that represents the major cytotoxic activity. This toxin exhibits strong hemolytic activity towards erythrocytes of various species. Notably, anti-CctA antibodies can fully neutralize hemolysis on standard blood-agar medium or in cell-free supernatants of liquid cultures.
Career Highlights
Throughout his career, Keith has worked with reputable organizations, including Intervet International B.V. and Universität Bern. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Keith has collaborated with notable colleagues such as Joachim Frey and Edy M Vilei. These partnerships have enriched his research endeavors and fostered innovation in his field.
Conclusion
Keith Redhead's contributions to the field of biotechnology through his patent and collaborations highlight his role as an influential inventor. His work continues to impact the understanding of cytotoxic activities and their applications.